About Sethera Therapeutics
Sethera Therapeutics is a private company based in Salt Lake City, Utah, incorporated in 2024 in Delaware. It has reported $1,949,463 raised in one offering on Form D since October 2024. Its chief executive is Karsten Eastman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 15, 2024 | Oct 30, 2024 | $1,949,463of $3.0M target | 21 | $92,832 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Sethera Therapeutics's Form D filed Oct 30, 2024.
VB
Vahe Bandarian
Executive officer and director
KE
Karsten Eastman
Chief Executive Officer and director
CT
Cynthia Tsai
Executive officer and director
YK
Yakov Kogan
Executive officer